Open AccessTocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
Author(s) -
Sameer Bansal,
Uma Karjigi,
Ravindra Mehta
Publication year - 2021
Publication title -
apollo medicine
Language(s) - English
Resource type - Journals
eISSN - 2213-3682
pISSN - 0976-0016
DOI - 10.4103/am.am_88_21
Subject(s) - tocilizumab , medicine , pneumonia , cytokine release syndrome , cytokine storm , confidence interval , hazard ratio , covid-19 , rheumatoid arthritis , disease , infectious disease (medical specialty)